Home  |   Archive  |   Online Submission  |   News & Events  |   Subscribe  |   APFA  |   Society  |   Contact Us  |   中文版
Search   
 
Journal

Ahead of print
Authors' Accepted
    Manuscripts
new!
Current Issue
Archive
Acknowledgments
Special Issues
Browse by Category

Manuscript Submission

Online Submission
Online Review
Instruction for Authors
Instruction for Reviewers
English Corner new!

About AJA

About AJA
Editorial Board
Contact Us
News

Resources & Services

Advertisement
Subscription
Email alert
Proceedings
Reprints

Download area

Copyright licence
EndNote style file
Manuscript word template
Guidance for AJA figures
    preparation (in English)

Guidance for AJA figures
    preparation (in Chinese)

Proof-reading for the
    authors

AJA Club (in English)
AJA Club (in Chinese)

 
Abstract

Volume 8, Issue 1 (January 2006) 8, 75–79; 10.1111/j.1745-7262.2006.00099.x

Peyronie's disease: a silent consequence of diabetes mellitus

A Tefekli, E Kandirali, B Erol, M Tunc and A Kadioglu

1.Department of Urology, Istanbul University, Istanbul Medical Faculty, Istanbul 343 90, Turkey
2.Department of Urology, Izzet Baysal Medical Faculty, Abant Izzet Baysal University, Bolu 14 280, Turkey

Correspondence: Dr Ates Kadioglu, M.D., Department of Urology, Istanbul University, Istanbul Medical Faculty, Istanbul 34390, Turkey. Fax: +90-212-6358-184. E-mail: kadiogluates@ttnet.net.tr

Received 15 November 2004; Accepted 12 April 2005.

Abstract

Aim: To investigate the clinical characteristics of patients with Peyronie's disease (PD) and diabetes mellitus (DM).

Methods: During an 8-year period, a total of 307 men seen at our outpatient clinic were diagnosed with PD. Clinical characteristics, penile deformities and the erectile status of patients with PD and DM together (n= 102) were retrospectively analyzed and compared to patients with PD alone with no risk factors for systemic vascular diseases (n= 97).

Results: The prevalence of PD among men with DM and sexual dysfunction was 10.7 %. The mean age of diabetic patients with PD was (55.9 8.9) years; in the no risk factor group it was (48.5 9.0) years (P < 0.05). The median duration of DM was 5 years. The majority of diabetic patients with PD (56.0 %) presented in the chronic phase (P < 0.05), and they were more likely to have a severe penile deformity (> 60°) than the no risk factor group (P < 0.05). In the diabetic group, the most common presenting symptom was penile curvature (81.4 %), followed by a palpable nodule on the shaft of the penis (22.5 %) and penile pain with erection (14.7 %). A total of 19.6 % of patients were not aware of their penile deformities in the diabetic group. Erectile function, provided by history and in response to intracavernosal injection and a stimulation test, was significantly diminished in patients with PD and DM (P < 0.05).

Conclusion: DM probably exaggerates the fibrotic process in PD. Diabetic patients with PD have a higher risk of severe deformity and erectile dysfunction (ED). PD seems to be a silent consequence of DM and should be actively sought in diabetic men.

Keywords: Peyronie's disease, diabetes mellitus, erectile dysfunction, penile deformity, fibrosis

Full Text | PDF |

 
Browse:  3682
 
Asian Journal of Andrology CN 31-1795/R ISSN 1008-682X  Copyright © 2023  Shanghai Materia Medica, Chinese Academy of Sciences.  All rights reserved.